@prefix	rdfs:	<http://www.w3.org/2000/01/rdf-schema#>	.
@prefix	local:	<http://local/local.owl#>	.
@prefix	ncit:	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#>	.
@prefix	rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#>	.
@prefix	owl:	<http://www.w3.org/2002/07/owl#>	.

#### Statements ####

local:s6.2	a	rdf:Statement	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s6.1	a	rdf:Statement	;
	rdfs:label	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s6	a	rdf:Statement	;
	rdfs:label	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s5.2	a	rdf:Statement	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s5.1	a	rdf:Statement	;
	rdfs:label	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s5	a	rdf:Statement	;
	rdfs:label	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:s4	a	rdf:Statement	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive generalized myasthenia gravis compared with placebo"	.

local:s3.1	a	rdf:Statement	;
	rdfs:label	"observing this study"	.

local:s3	a	rdf:Statement	;
	rdfs:label	"rituximab was safe these results suggest that there is a low probability of observing this study"	.

local:s2.2	a	rdf:Statement	;
	rdfs:label	"observing this study"	.

local:s2.1	a	rdf:Statement	;
	rdfs:label	"these results suggest that there is a low probability of observing this study"	.

local:s2	a	rdf:Statement	;
	rdfs:label	"rituximab welltolerated these results"	.

local:s1.1	a	rdf:Statement	;
	rdfs:label	"rituximab warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	.

local:s1	a	rdf:Statement	;
	rdfs:label	"determine whether rituximab is safe warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	.

local:s0	a	rdf:Statement	;
	rdfs:label	"determine whether rituximab is potentially beneficial warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	.


#### Classes ####

local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	a	rdf:Class	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive rituximab"	.

local:mild	a	rdf:Class	;
	rdfs:label	"mild"	.

local:acetylcholine_receptor	a	rdf:Class	;
	rdfs:label	"acetylcholine receptor"	.

local:antibodypositive_rituximab	a	rdf:Class	;
	rdfs:label	"antibodypositive rituximab"	.

local:rituximab	a	rdf:Class	;
	rdfs:label	"rituximab"	.

local:receptor	a	rdf:Class	;
	rdfs:label	"receptor"	.

local:acetylcholine	a	rdf:Class	;
	rdfs:label	"acetylcholine"	.

local:antibodypositive	a	rdf:Class	;
	rdfs:label	"antibodypositive"	.

local:receptor_antibodypositive_rituximab	a	rdf:Class	;
	rdfs:label	"receptor antibodypositive rituximab"	.

local:acetylcholine_receptor_antibodypositive_rituximab	a	rdf:Class	;
	rdfs:label	"acetylcholine receptor antibodypositive rituximab"	.

local:moderate_acetylcholine_receptor_antibodypositive_rituximab	a	rdf:Class	;
	rdfs:label	"moderate acetylcholine receptor antibodypositive rituximab"	.

local:reduce	a	rdf:Class	;
	rdfs:label	"reduce"	.

local:steroid_use_absolute_difference_of_at_least_30_percent	a	rdf:Class	;
	rdfs:label	"steroid use absolute difference of at least 30 percent"	.

local:steroid_use	a	rdf:Class	;
	rdfs:label	"steroid use"	.

local:absolute_difference	a	rdf:Class	;
	rdfs:label	"absolute difference"	.

local:percent	a	rdf:Class	;
	rdfs:label	"percent"	.

local:absolute	a	rdf:Class	;
	rdfs:label	"absolute"	.

local:steroid	a	rdf:Class	;
	rdfs:label	"steroid"	.

local:difference	a	rdf:Class	;
	rdfs:label	"difference"	.

local:use	a	rdf:Class	;
	rdfs:label	"use"	.

local:30_percent	a	rdf:Class	;
	rdfs:label	"30 percent"	.

local:least_30	a	rdf:Class	;
	rdfs:label	"least 30"	.

local:30	a	rdf:Class	;
	rdfs:label	"30"	.

local:absolute_difference_of_30_percent	a	rdf:Class	;
	rdfs:label	"absolute difference of 30 percent"	.

local:1_year	a	rdf:Class	;
	rdfs:label	"1 year"	.

local:year	a	rdf:Class	;
	rdfs:label	"year"	.

local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	a	rdf:Class	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:reduce_by_absolute_difference	a	rdf:Class	;
	rdfs:label	"reduce by absolute difference"	.

local:reduce_by_absolute_difference_at_1_year	a	rdf:Class	;
	rdfs:label	"reduce by absolute difference at 1 year"	.

local:evidence	a	rdf:Class	;
	rdfs:label	"evidence"	.

local:study	a	rdf:Class	;
	rdfs:label	"study"	.

local:provide	a	rdf:Class	;
	rdfs:label	"provide"	.

local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	a	rdf:Class	;
	rdfs:label	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:class_i_evidence	a	rdf:Class	;
	rdfs:label	"class i evidence"	.

local:class_i	a	rdf:Class	;
	rdfs:label	"class i"	.

local:class	a	rdf:Class	;
	rdfs:label	"class"	.

local:i_evidence	a	rdf:Class	;
	rdfs:label	"i evidence"	.

local:i	a	rdf:Class	;
	rdfs:label	"i"	.

local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	a	rdf:Class	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	a	rdf:Class	;
	rdfs:label	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	.

local:mild_to_moderate_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"mild to moderate acetylcholine receptor antibodypositive generalize myasthenia gravis"	.

local:antibodypositive_generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"antibodypositive generalize myasthenia gravis"	.

local:antibodypositive_generalize_myasthenia	a	rdf:Class	;
	rdfs:label	"antibodypositive generalize myasthenia"	.

local:antibodypositive_generalize	a	rdf:Class	;
	rdfs:label	"antibodypositive generalize"	.

local:generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"generalize myasthenia gravis"	.

local:gravis	a	rdf:Class	;
	rdfs:label	"gravis"	.

local:myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"myasthenia gravis"	.

local:myasthenia	a	rdf:Class	;
	rdfs:label	"myasthenia"	.

local:generalize_myasthenia	a	rdf:Class	;
	rdfs:label	"generalize myasthenia"	.

local:generalize	a	rdf:Class	;
	rdfs:label	"generalize"	.

local:moderate_acetylcholine_receptor	a	rdf:Class	;
	rdfs:label	"moderate acetylcholine receptor"	.

local:mild_to_moderate_acetylcholine_receptor	a	rdf:Class	;
	rdfs:label	"mild to moderate acetylcholine receptor"	.

local:compare	a	rdf:Class	;
	rdfs:label	"compare"	.

local:placebo	a	rdf:Class	;
	rdfs:label	"placebo"	.

local:observe	a	rdf:Class	;
	rdfs:label	"observe"	.

local:rituximab_be_safe_these_result	a	rdf:Class	;
	rdfs:label	"rituximab be safe these result"	.

local:result	a	rdf:Class	;
	rdfs:label	"result"	.

local:result_safe	a	rdf:Class	;
	rdfs:label	"result safe"	.

local:safe	a	rdf:Class	;
	rdfs:label	"safe"	.

local:suggest	a	rdf:Class	;
	rdfs:label	"suggest"	.

local:low_probability_of_observe_this_study	a	rdf:Class	;
	rdfs:label	"low probability of observe this study"	.

local:low_probability	a	rdf:Class	;
	rdfs:label	"low probability"	.

local:probability	a	rdf:Class	;
	rdfs:label	"probability"	.

local:low	a	rdf:Class	;
	rdfs:label	"low"	.

local:welltolerated	a	rdf:Class	;
	rdfs:label	"welltolerated"	.

local:warrant	a	rdf:Class	;
	rdfs:label	"warrant"	.

local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	.

local:efficacy_trial	a	rdf:Class	;
	rdfs:label	"efficacy trial"	.

local:investigation	a	rdf:Class	;
	rdfs:label	"investigation"	.

local:efficacy	a	rdf:Class	;
	rdfs:label	"efficacy"	.

local:trial	a	rdf:Class	;
	rdfs:label	"trial"	.

local:investigation_in_efficacy_trial	a	rdf:Class	;
	rdfs:label	"investigation in efficacy trial"	.

local:efficacy_trial_for_acetylcholine_receptor	a	rdf:Class	;
	rdfs:label	"efficacy trial for acetylcholine receptor"	.

local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	.

local:further_investigation	a	rdf:Class	;
	rdfs:label	"further investigation"	.

local:safe_warrant	a	rdf:Class	;
	rdfs:label	"safe warrant"	.

local:further	a	rdf:Class	;
	rdfs:label	"further"	.

local:further_investigation_in_efficacy_trial	a	rdf:Class	;
	rdfs:label	"further investigation in efficacy trial"	.

local:determine	a	rdf:Class	;
	rdfs:label	"determine"	.

local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	a	rdf:Class	;
	rdfs:label	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	.

local:potentially_beneficial_warrant	a	rdf:Class	;
	rdfs:label	"potentially beneficial warrant"	.

local:potentially_beneficial	a	rdf:Class	;
	rdfs:label	"potentially beneficial"	.

local:beneficial	a	rdf:Class	;
	rdfs:label	"beneficial"	.

local:beneficial_warrant	a	rdf:Class	;
	rdfs:label	"beneficial warrant"	.

local:potentially	a	rdf:Class	;
	rdfs:label	"potentially"	.

#### Mapped Relations ####

local:absolute	owl:sameAs	ncit:C45829	.
local:result	owl:sameAs	ncit:C76125	.
ncit:C49156	rdfs:label	"Comparison"	.
ncit:C88183	rdfs:label	"Efficacy"	.
local:class	owl:sameAs	ncit:C25346	.
ncit:C142675	rdfs:label	"SAFE-Biopharma Standard"	.
ncit:C71104	rdfs:label	"Clinical Trial"	.
local:probability	owl:sameAs	ncit:C54154	.
local:class_i	owl:sameAs	ncit:C77265	.
local:use	owl:sameAs	ncit:C25340	.
local:efficacy	owl:sameAs	ncit:C88183	.
local:trial	owl:sameAs	ncit:C71104	.
local:year	owl:sameAs	ncit:C29848	.
local:provide	owl:sameAs	ncit:C80514	.
local:acetylcholine	owl:sameAs	ncit:C77840	.
local:steroid	owl:sameAs	ncit:C843	.
local:low	owl:sameAs	ncit:C54722	.
ncit:C41198	rdfs:label	"Investigation"	.
ncit:C18106	rdfs:label	"Receptor"	.
ncit:C25346	rdfs:label	"Class"	.
local:suggest	owl:sameAs	ncit:C48313	.
local:percent	owl:sameAs	ncit:C48570	.
ncit:C25340	rdfs:label	"Use"	.
local:difference	owl:sameAs	ncit:C46003	.
local:investigation	owl:sameAs	ncit:C41198	.
ncit:C48313	rdfs:label	"Suggestion"	.
ncit:C29848	rdfs:label	"Year"	.
local:safe	owl:sameAs	ncit:C142675	.
local:placebo	owl:sameAs	ncit:C753	.
ncit:C1702	rdfs:label	"Rituximab"	.
ncit:C843	rdfs:label	"Steroid Compound"	.
ncit:C80514	rdfs:label	"Provide"	.
ncit:C136827	rdfs:label	"Determine"	.
local:determine	owl:sameAs	ncit:C136827	.
ncit:C43583	rdfs:label	"Evidence"	.
local:evidence	owl:sameAs	ncit:C43583	.
ncit:C54154	rdfs:label	"Probability"	.
local:receptor	owl:sameAs	ncit:C18106	.
ncit:C48570	rdfs:label	"Percent Unit"	.
ncit:C46003	rdfs:label	"Difference"	.
local:rituximab	owl:sameAs	ncit:C1702	.
ncit:C77265	rdfs:label	"Canadian Cardiovascular Society Grading Scale Class I"	.
ncit:C63536	rdfs:label	"Study"	.
local:myasthenia_gravis	owl:sameAs	ncit:C60989	.
ncit:C54722	rdfs:label	"Low"	.
ncit:C77840	rdfs:label	"Acetylcholine"	.
ncit:C76125	rdfs:label	"Experimental Result"	.
ncit:C753	rdfs:label	"Placebo"	.
ncit:C45829	rdfs:label	"Absolute"	.
ncit:C60989	rdfs:label	"Myasthenia Gravis"	.
local:compare	owl:sameAs	ncit:C49156	.
local:study	owl:sameAs	ncit:C63536	.

#### Relations ####

local:s6.2	local:AM-TMP	local:1_year	.
local:low_probability_of_observe_this_study	rdfs:member	local:study	.
local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:investigation	.
local:s3	rdf:subject	local:rituximab_be_safe_these_result	.
local:antibodypositive_generalize	rdfs:subClassOf	local:generalize	.
local:1_year	rdfs:subClassOf	local:year	.
local:investigation_in_efficacy_trial	rdfs:member	local:investigation	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:year	.
local:least_30	rdfs:subClassOf	local:30	.
local:s3	rdf:predicate	local:suggest	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:acetylcholine_receptor	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:steroid_use	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:absolute_difference	.
local:s2.1	rdf:predicate	local:suggest	.
local:antibodypositive_generalize_myasthenia	rdfs:member	local:antibodypositive_generalize	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:efficacy_trial	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:safe_warrant	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:steroid_use	.
local:acetylcholine_receptor_antibodypositive_rituximab	rdfs:subClassOf	local:receptor_antibodypositive_rituximab	.
local:rituximab_be_safe_these_result	rdfs:member	local:rituximab	.
local:s2.2	rdf:subject	local:study	.
local:s6.1	rdf:predicate	local:evidence	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	rdfs:member	local:acetylcholine_receptor	.
local:s5.2	local:AM-TMP	local:1_year	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:acetylcholine_receptor	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:absolute_difference	.
local:s2	rdf:subject	local:rituximab	.
local:s6	rdf:object	local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:mild	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:percent	.
local:s5.2	rdf:subject	local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:rituximab	.
local:myasthenia_gravis	rdfs:member	local:myasthenia	.
local:reduce_by_absolute_difference_at_1_year	rdfs:member	local:1_year	.
local:s5.2	rdf:predicate	local:reduce	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:class_i_evidence	.
local:moderate_acetylcholine_receptor	rdfs:subClassOf	local:acetylcholine_receptor	.
local:beneficial_warrant	rdfs:subClassOf	local:warrant	.
local:s4	rdf:subject	local:mild_to_moderate_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	.
local:s2.2	rdf:predicate	local:observe	.
local:steroid_use_absolute_difference_of_at_least_30_percent	rdfs:member	local:steroid_use	.
local:s1	rdf:subject	local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	.
local:result_safe	rdfs:subClassOf	local:safe	.
local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:efficacy_trial	.
local:class_i	rdfs:member	local:class	.
local:class_i_evidence	rdfs:member	local:class_i	.
local:s1.1	rdf:subject	local:rituximab	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	rdfs:member	local:moderate_acetylcholine_receptor_antibodypositive_rituximab	.
local:beneficial_warrant	rdfs:member	local:beneficial	.
local:further_investigation	rdfs:member	local:further	.
local:s6	rdf:subject	local:study	.
local:antibodypositive_rituximab	rdfs:subClassOf	local:rituximab	.
local:antibodypositive_generalize_myasthenia	rdfs:subClassOf	local:myasthenia	.
local:s3.1	rdf:subject	local:study	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:acetylcholine_receptor	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:percent	.
local:potentially_beneficial_warrant	rdfs:subClassOf	local:warrant	.
local:low_probability	rdfs:member	local:low	.
local:s3.1	rdf:predicate	local:observe	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:antibodypositive_generalize_myasthenia_gravis	.
local:absolute_difference	rdfs:member	local:absolute	.
local:class_i	rdfs:subClassOf	local:i	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:mild	.
local:generalize_myasthenia	rdfs:member	local:generalize	.
local:investigation_in_efficacy_trial	rdfs:member	local:efficacy_trial	.
local:efficacy_trial	rdfs:member	local:efficacy	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:further_investigation	.
local:antibodypositive_generalize	rdfs:member	local:antibodypositive	.
local:moderate_acetylcholine_receptor_antibodypositive_rituximab	rdfs:subClassOf	local:acetylcholine_receptor_antibodypositive_rituximab	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:mild	.
local:absolute_difference_of_30_percent	rdfs:member	local:absolute_difference	.
local:s6	rdf:predicate	local:provide	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:acetylcholine_receptor	.
local:i_evidence	rdfs:subClassOf	local:evidence	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:absolute_difference	.
local:low_probability_of_observe_this_study	rdfs:member	local:observe	.
local:myasthenia_gravis	rdfs:subClassOf	local:gravis	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:class_i_evidence	.
local:steroid_use	rdfs:subClassOf	local:use	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:acetylcholine_receptor	.
local:s1.1	rdf:object	local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:antibodypositive_rituximab	.
local:efficacy_trial_for_acetylcholine_receptor	rdfs:member	local:acetylcholine_receptor	.
local:steroid_use	rdfs:member	local:steroid	.
local:potentially_beneficial_warrant	rdfs:member	local:potentially_beneficial	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	rdfs:member	local:mild	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:rituximab	.
local:reduce_by_absolute_difference	rdfs:member	local:reduce	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:acetylcholine_receptor	.
local:potentially_beneficial	rdfs:subClassOf	local:beneficial	.
local:further_investigation_in_efficacy_trial	rdfs:member	local:further_investigation	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:percent	.
local:s5	rdf:subject	local:study	.
local:class_i_evidence	rdfs:subClassOf	local:i_evidence	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:mild	.
local:efficacy_trial_for_acetylcholine_receptor	rdfs:member	local:efficacy_trial	.
local:s5.2	rdf:object	local:steroid_use_absolute_difference_of_at_least_30_percent	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:antibodypositive_generalize_myasthenia_gravis	.
local:potentially_beneficial	rdfs:member	local:potentially	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:year	.
local:mild_to_moderate_acetylcholine_receptor	rdfs:member	local:moderate_acetylcholine_receptor	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:mild	.
local:mild_to_moderate_acetylcholine_receptor	rdfs:member	local:mild	.
local:s2.1	rdf:object	local:low_probability_of_observe_this_study	.
local:generalize_myasthenia	rdfs:subClassOf	local:myasthenia	.
local:s5	rdf:object	local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:potentially_beneficial_warrant	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:antibodypositive_rituximab	.
local:rituximab_be_safe_these_result	rdfs:member	local:result	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:antibodypositive_generalize_myasthenia_gravis	.
local:reduce_by_absolute_difference	rdfs:member	local:absolute_difference	.
local:absolute_difference_of_30_percent	rdfs:member	local:30_percent	.
local:i_evidence	rdfs:member	local:i	.
local:safe_warrant	rdfs:subClassOf	local:warrant	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:acetylcholine_receptor	.
local:antibodypositive_generalize_myasthenia	rdfs:subClassOf	local:generalize_myasthenia	.
local:class_i_evidence	rdfs:subClassOf	local:evidence	.
local:s4	rdf:object	local:placebo	.
local:s0	rdf:predicate	local:determine	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:steroid_use	.
local:s6.2	rdf:predicate	local:reduce	.
local:antibodypositive_generalize_myasthenia_gravis	rdfs:subClassOf	local:gravis	.
local:s6.1	rdf:subject	local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	.
local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:antibodypositive_generalize_myasthenia_gravis	.
local:s2	rdf:object	local:result	.
local:s5.1	rdf:predicate	local:evidence	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:year	.
local:s1	rdf:predicate	local:determine	.
local:further_investigation	rdfs:subClassOf	local:investigation	.
local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:efficacy_trial	.
local:s6.2	rdf:subject	local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:percent	.
local:generalize_myasthenia_gravis	rdfs:subClassOf	local:gravis	.
local:s5	rdf:predicate	local:provide	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:steroid_use	.
local:s3	rdf:object	local:low_probability_of_observe_this_study	.
local:low_probability	rdfs:subClassOf	local:probability	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab	rdfs:member	local:antibodypositive_rituximab	.
local:acetylcholine_receptor	rdfs:subClassOf	local:receptor	.
local:further_investigation_in_efficacy_trial	rdfs:member	local:efficacy_trial	.
local:generalize_myasthenia_gravis	rdfs:member	local:generalize_myasthenia	.
local:s2	rdf:predicate	local:welltolerated	.
local:receptor_antibodypositive_rituximab	rdfs:subClassOf	local:antibodypositive_rituximab	.
local:s1.1	rdf:predicate	local:warrant	.
local:absolute_difference	rdfs:subClassOf	local:difference	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:antibodypositive_rituximab	.
local:s0	rdf:subject	local:whether_rituximab_be_potentially_beneficial_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	.
local:antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:antibodypositive_generalize_myasthenia	.
local:class_i_evidence_that_for_mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:year	.
local:efficacy_trial	rdfs:subClassOf	local:trial	.
local:whether_rituximab_be_safe_warrant_further_investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:further_investigation	.
local:reduce_by_absolute_difference_at_1_year	rdfs:member	local:reduce_by_absolute_difference	.
local:acetylcholine_receptor	rdfs:member	local:acetylcholine	.
local:s6.2	rdf:object	local:steroid_use_absolute_difference_of_at_least_30_percent	.
local:s5.1	rdf:subject	local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	.
local:safe_warrant	rdfs:member	local:safe	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_safe_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:antibodypositive_rituximab	.
local:steroid_use_absolute_difference_of_at_least_30_percent	rdfs:member	local:absolute_difference	.
local:s4	rdf:predicate	local:compare	.
local:steroid_use_absolute_difference_of_at_least_30_percent	rdfs:member	local:percent	.
local:30_percent	rdfs:subClassOf	local:percent	.
local:investigation_in_an_efficacy_trial_for_acetylcholine_receptor_antibodypositive_generalize_myasthenia_gravis	rdfs:member	local:acetylcholine_receptor	.
local:mild_to_moderate_acetylcholine_receptor_antibodypositive_rituximab_be_unlikely_to_reduce_steroid_use_by_an_absolute_difference_of_at_least_30_percent_at_1_year	rdfs:member	local:absolute_difference	.
local:low_probability_of_observe_this_study	rdfs:member	local:low_probability	.
local:s2.1	rdf:subject	local:result	.
local:antibodypositive_rituximab	rdfs:member	local:antibodypositive	.
